Processa Pharmaceuticals Inc (PCSA)
1.06
-0.01
(-0.93%)
USD |
NASDAQ |
Nov 14, 16:00
1.06
0.00 (0.00%)
After-Hours: 17:52
Processa Pharmaceuticals Shareholders Equity (Quarterly): 6.024M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 6.024M |
March 31, 2024 | 8.883M |
December 31, 2023 | 4.989M |
September 30, 2023 | 7.168M |
June 30, 2023 | 9.160M |
March 31, 2023 | 10.14M |
December 31, 2022 | 7.471M |
September 30, 2022 | 17.24M |
June 30, 2022 | 20.08M |
March 31, 2022 | 23.24M |
December 31, 2021 | 25.49M |
September 30, 2021 | 27.21M |
June 30, 2021 | 29.24M |
March 31, 2021 | 31.34M |
December 31, 2020 | 22.94M |
September 30, 2020 | 5.527M |
June 30, 2020 | 6.593M |
March 31, 2020 | 7.234M |
December 31, 2019 | 8.012M |
September 30, 2019 | 8.671M |
June 30, 2019 | 8.502M |
March 31, 2019 | 9.124M |
December 31, 2018 | 9.701M |
September 30, 2018 | 10.51M |
Date | Value |
---|---|
June 30, 2018 | 11.31M |
March 31, 2018 | 7.276M |
December 31, 2017 | 0.3732M |
September 30, 2017 | -0.0351M |
June 30, 2017 | -2.491M |
March 31, 2017 | -2.437M |
December 31, 2016 | -2.351M |
September 30, 2016 | -2.250M |
June 30, 2016 | -2.170M |
March 31, 2016 | -2.118M |
December 31, 2015 | -1.979M |
September 30, 2015 | -1.618M |
June 30, 2015 | -1.320M |
March 31, 2015 | 0.7018M |
December 31, 2014 | 1.208M |
September 30, 2014 | -0.1168M |
June 30, 2014 | 0.623M |
March 31, 2014 | 1.030M |
December 31, 2013 | 1.671M |
September 30, 2013 | 2.377M |
June 30, 2013 | 1.010M |
March 31, 2013 | 1.735M |
December 31, 2012 | 2.562M |
September 30, 2012 | 3.056M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
4.989M
Minimum
Dec 2023
31.34M
Maximum
Mar 2021
14.63M
Average
9.160M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -0.617M |
Palatin Technologies Inc | -0.1115M |
iBio Inc | 21.32M |
Theriva Biologics Inc | 27.65M |
Oragenics Inc | 1.326M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 7.601M |
Total Liabilities (Quarterly) | 1.577M |